Iodine × 甲狀腺功能

結論:證據不足

碘對甲狀腺功能的充足攝取具備 S 級機轉確定性(T3/T4 底物),並有 WHO USI 公衛政策、多國監管機構(FDA/EFSA/TFDA/WHO)一致的 supportive 立場,加上 NIH ODS、ATA、Endocrine Society 等學會的強烈建議。

U ⚫ U 未驗證 證據不足 low — community discussion mostly non-commercial
⚠️ 標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用
⚗️ 研究進行中:本主題證據仍在累積、尚無定論;部分介入屬試驗階段,未必已在台上市或可購得。

碘對甲狀腺功能的充足攝取具備 S 級機轉確定性(T3/T4 底物),並有 WHO USI 公衛政策、多國監管機構(FDA/EFSA/TFDA/WHO)一致的 supportive 立場,加上 NIH ODS、ATA、Endocrine Society 等學會的強烈建議。

然而,由於「充足攝取支持、過量有害」的雙向 U 型曲線在 Teng 2006 NEJM(n=3,018)與 Laurberg DanThyr 等高品質研究中均獲確認,且 Examine 資料庫因 RCT 補充劑鏡頭缺失 USI 公衛證據(所有結果均為 C 級 surrogate),本層給予 A 而非 S——反映「充足攝取領域 S 級,但需在 AITD/過量脈絡加入明確限制語」的謹慎取向。

內容發布應附完整 UL 與 AITD 警語。

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.66
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
U · 證據不足
信心度
75%
證據方向大致一致
證據層級
E8
世代研究/觀察性證據

各層「支持此療效」的程度

分數越低=該層越不支持
L1 Examine國際基準
0.50
L3 機轉生理合理性
0.50
L5 臨床機構權威立場
0.62
L11 AI 複核獨立判讀
0.80
L2 PubMed原始文獻
0.85
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.664
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 僅有 E8 級證據 (cohort/animal/mechanism),不足以下結論
  4. apply_hec_override — HEC-4 僅低階證據 (E8-E10) — 強制由 B 改為 U
  5. tier_strict_requirement_check — Tier 條件達標,未降階
  6. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  7. decide_status — 依 tier + dispute 結果決定 status

Iodine deficiency.
PMID: 19460960 2008 Other
結論:Comprehensive synthesis confirming iodine deficiency as the leading preventable cause of intellectual disability worldwide; even mild-moderate deficiency in pregnancy is associated with reduced child IQ. Universal salt iodization is the primary public-health intervention; correction reverses goiter and overt hypothyroidism at population level. Excess iodine is also reviewed as harmful (see bidirectional caveat).
🟢 高品質 學術資助 效應量:Population goiter prevalence falls sharply with UIC normalization; child IQ deficit ~13.5 points in severe deficiency areas vs replete populations (cited meta-analysis)
前往 PubMed
Effect of iodine intake on thyroid diseases in China
PMID: 16807415 2006 Cohort n = 3,018
結論:Bidirectional risk demonstrated: more-than-adequate (UIC 243) and excessive (UIC 651) iodine intake significantly increased incidence of subclinical hypothyroidism (2.6% and 6.1% vs 0.2% in mildly deficient region, p<0.001) and autoimmune thyroiditis. Mildly deficient region had higher incidence of goiter and hyperthyroidism. Conclusion: 'more than adequate or excessive iodine intake may lead to hypothyroidism and autoimmune thyroiditis.' Anchor citation for excess-iodine harm.
🟢 高品質 政府資助 效應量:Subclinical hypothyroidism cumulative incidence: 0.2% (deficient) vs 2.6% (more-than-adequate) vs 6.1% (excessive); autoimmune thyroiditis incidence ~3-fold higher in excess vs deficient region
前往 PubMed
Consequences of excess iodine
PMID: 24342882 2014 Other
結論:Acute iodine load triggers transient Wolff-Chaikoff effect (autoregulatory inhibition of thyroid hormone synthesis lasting ~24-48h); failure to escape causes iodine-induced hypothyroidism, especially in fetuses, neonates, the elderly, and patients with underlying Hashimoto's. Chronic excess can precipitate autoimmune thyroiditis (rising TPOAb) and, in iodine-deficient nodular populations, Jod-Basedow hyperthyroidism. Vulnerable subgroups: pregnancy, neonates, autoimmune thyroid disease, prior partial thyroidectomy.
🟢 高品質 學術資助 效應量:Qualitative; cites multiple cohorts where supraphysiologic intake (>500 mcg/day) increases hypothyroidism risk 2-3 fold in susceptible groups
前往 PubMed
Global iodine nutrition: where do we stand in 2013? (Pearce EN, Andersson M, Zimmermann MB; Thyroid)
PMID: 23472655 2013 Other
結論:111 of 152 countries had adequate iodine intake at survey time; 30 remained deficient; 11 had excessive intake (median UIC >300 mcg/L, including parts of coastal East Asia). Reinforces that universal salt iodization works at population scale and that surveillance must monitor BOTH deficiency AND excess. Pregnant women remain a vulnerable subgroup with persistent mild deficiency in many countries deemed sufficient overall.
🟢 高品質 學術資助 效應量:Population goiter prevalence reduced where salt iodization sustained; cohort data on pregnancy iodine status as predictor of offspring neurocognition cited
前往 PubMed
Global iodine status in 2011 and trends over the past decade (Andersson M, Karumbunathan V, Zimmermann MB; J Nutr)
PMID: 22378324 2012 Cross-sectional
結論:Number of iodine-deficient countries fell from 54 (2003) to 32 (2011); however 9 countries (including USA, Australia, UK in subgroups) shifted into mild deficiency, and several (e.g., Brazil, parts of Asia/Africa) moved into excess. Demonstrates that iodine sufficiency is a moving target requiring ongoing surveillance and that BOTH under- and over-correction are documented in real populations. Supports the bidirectional public-health framing.
🟢 高品質 政府資助 效應量:Reduction in deficient-country count from 54 to 32 over 8 years; concurrent emergence of excess in selected countries
前往 PubMed
Iodine intake as a determinant of thyroid disorders in populations (Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB, Carle A; Best Pract Res Clin Endocrinol Metab)
PMID: 20172467 2010 Cohort
結論:Iodine intake shows a U-shaped relationship with thyroid disease: low intake increases nodular goiter and toxic nodular hyperthyroidism in older adults; replete-to-high intake increases autoimmune (Hashimoto) hypothyroidism. Following Danish mandatory iodization (raising intake from ~50 to ~100 mcg/day), incidence of hyperthyroidism initially rose (Jod-Basedow in pre-existing nodular goiter) and overt hypothyroidism subsequently increased. Confirms bidirectional caveat at the cohort level and warns against megadose correction.
🟢 高品質 政府資助 效應量:Hyperthyroidism incidence ~50% rise in first 3 years post-iodization (transient); hypothyroidism incidence rose ~30-50% over follow-up in iodine-replete vs deficient cohort
前往 PubMed
2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum (Alexander EK et al.; Thyroid)
PMID: 28056690 2017 Other
結論:ATA position: routine 150 mcg/day potassium iodide in pregnancy/lactation in non-deficient countries (Strong/Moderate). Explicit caution against megadose iodine (>500 mcg/day sustained) due to risk of fetal/neonatal hypothyroidism via Wolff-Chaikoff effect. Discourages kelp and seaweed supplements due to unpredictable iodine content. Operationalizes the bidirectional principle in clinical guidance.
🟢 高品質 學術資助 效應量:Guideline-level recommendations; not a primary effect estimate
前往 PubMed

L4a US FDA
支持
Iodized salt or iodized table salt is the article of commerce, salt for human food use, to which has been added cuprous iodide or potassium iodide. The label shall bear the statement 'This salt supplies iodide, a necessary nutrient'. Cuprous iodide and potassium iodide may be added to table salt as a source of dietary iodine in an amount not greater than 0.01 percent. 來源↗
L4b EU EFSA
支持
Iodine contributes to normal cognitive function, normal functioning of the nervous system, the maintenance of normal skin, normal production of thyroid hormones and normal thyroid function, and contributes to normal growth of children 來源↗
L4c UK NHS
謹慎
Adults need 140 micrograms (μg) of iodine a day. Most people should be able to get all the iodine they need by eating a varied and balanced diet. Taking high doses of iodine for long periods of time could change the way your thyroid gland works. This can lead to a wide range of different symptoms, such as weight gain. Taking 0.5mg or less a day of iodine supplements is unlikely to cause any harm. 來源↗
L4d TW TFDA / 衛福部
支持
孕婦碘的每日建議攝取量為225微克,較一般成人140微克高出許多;衛生福利部建議孕婦及哺乳婦使用加碘鹽,並可適量攝取含碘量豐富的食物,如海帶、海藻類等。 來源↗
L4e WHO
支持
All food-grade salt, used in household and food processing should be fortified with iodine as a safe and effective strategy for the prevention and control of iodine deficiency disorders in populations living in stable and emergency settings. 來源↗

L5a NIH Office of Dietary Supplements
支持
Iodine is a mineral found in some foods. The body needs iodine to make thyroid hormones. These hormones control the body's metabolism and many other important functions. The body also needs thyroid hormones for proper bone and brain development during pregnancy and infancy. 來源↗
L5b Mayo Clinic
支持
L5c Cleveland Clinic
支持
Your thyroid needs iodine to produce thyroid hormone. 來源↗
L5d Harvard Health
支持
Iodine is needed to make the thyroid hormones thyroxine and triiodothyronine, which assist with the creation of proteins and enzyme activity, as well as regulating normal metabolism. ... High-dose iodine supplements are not always advised, as they can cause thyroid problems in some women. 來源↗
L5e Specialty Society (condition-mapped)
反對

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 低度
📍立場總覽

台灣社群對「碘 × 甲狀腺」的討論多圍繞飲食(海帶/紫菜/碘鹽)與甲狀腺癌術後 I-131 低碘飲食,而非把碘當保健品單獨補充。鄉民普遍知道甲狀腺亢進/自體免疫者要少碘、缺碘性腫大才需補碘,並強調以碘鹽與天然食物為主、不依賴補充劑。討論真實、業配極少。

💬社群實感

無共識(多為飲食/醫療情境分享,非保健品療效)

破解迷思 社群最常見的 5 個誤解
迷思多吃海帶/紫菜補碘就能消「大脖子」
事實對甲狀腺亢進或自體免疫甲狀腺炎者反而有害
迷思有甲狀腺問題就要多補碘
事實實際上亢進與低下對碘需求相反,不能一概而論
迷思台灣海帶碘含量穩定可靠
事實實際因產地/氣候差異極大,無法當穩定碘來源
迷思碘補越多越好
事實過量碘同樣會引起甲狀腺腫大與誘發甲狀腺疾病
迷思保健品/海藻精補碘比碘鹽好
事實社群與營養師反而傾向以碘鹽+天然食物為主
🩹 社群通報的副作用
  • 碘攝取過量引起甲狀腺腫大
  • 高碘飲食誘發或加重甲狀腺機能亢進
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • 台鹽加碘鹽(碘酸鉀)/氟碘鹽(作為日常碘來源,非保健品)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

查看代表討論串 ↗

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

台鹽健康加碘鹽 1kg NT$35(碘 20-33 mg/kg)

代表來源 ↗
L10b · TFDA 法定身份 官方認定

碘為必需營養素。本產品加碘。但甲狀腺病人應諮詢相關醫師意見。

來源 ↗

  • 左旋甲狀腺素(Levothyroxine)替代治療
  • 抗甲狀腺藥物(如 methimazole)
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 7 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v35 engine_version: v1.0 claim_id: CLM-COND-thyroid-function-INT-iodine-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-thyroid-function-INT-iodine-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "碘能改善甲狀腺功能",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "alternateName": "證據不足 (Insufficient evidence)"
  }
}